Table: Oncolys Biopharma - Q1 parent results

Oncolys Biopharma

10/05/2024 07:00

May 10 (Reuters)- 
             Oncolys Biopharma Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2024        Mar 31, 2023     Dec 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales                                35 mln                     
                (-100.0 pct)         (-81.9 pct)                  
  Operating     loss 378 mln        loss 325 mln                  
  Recurring     loss 363 mln        loss 323 mln                  
  Net           loss 364 mln        loss 323 mln                  
  EPS          loss 18.24 yen      loss 18.69 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div                                NIL              NIL     
  -Q4 div                                NIL              NIL     
  
  NOTE - Oncolys Biopharma Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T